Patents by Inventor Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acetylcysteine Composition and Uses Thereof
    Publication number: 20130165516
    Abstract: This invention relates to novel acetylcysteine compositions in solution, comprising acetylcysteine and which are substantially free of metal chelating agents, such as EDTA. Further, this invention relates to methods of making and using the acetylcysteine compositions. The present compositions and methods are designed to improve patient tolerance and compliance, while at the same time maintaining the stability of the pharmaceutical formulation. The compositions and methods of this invention are useful in the treatment of acetaminophen overdose, acute liver failure, various cancers, methacrylonitrile poisoning, reperfusion injury during cardio bypass surgery, and radiocontrast-induced nephropathy, and can also be used as a mucolytic agent.
    Type: Application
    Filed: February 1, 2013
    Publication date: June 27, 2013
    Applicant: CUMBERLAND PHARMACEUTICALS, INC.
    Inventor: Cumberland Pharmaceuticals, Inc.
  • STABILIZED STATIN FORMULATIONS
    Publication number: 20130137745
    Abstract: The present invention is directed to statin formulations having improved solubility and/or stability and methods for the same.
    Type: Application
    Filed: January 22, 2013
    Publication date: May 30, 2013
    Applicant: Cumberland Pharmaceuticals Inc.
    Inventor: Cumberland Pharmaceuticals Inc.